Connect with us

Health

South African doctors see signs Omicron is milder than Delta

As the Omicron COVID-19 variant sweeps through South Africa, Dr. Unben Pillay is seeing dozens of sick patients a day. Yet he hasn’t had to send anyone to the hospital.

For the latest headlines, follow our Google News channel online or via the app.

That’s one of the reasons why he, along with other doctors and medical experts, suspect that the Omicron version really is causing milder COVID-19 than Delta, even if it seems to be spreading faster.

“They are able to manage the disease at home,” Pillay said of his patients. “Most have recovered within the 10 to 14-day isolation period.” said Pillay.

And that includes older patients and those with health problems that can make them more vulnerable to becoming severely ill from a coronavirus infection, he said.

In the two weeks since Omicron first was reported in Southern Africa, other doctors have shared similar stories. All caution that it will take many more weeks to collect enough data to be sure, their observations and the early evidence offer some clues.

According to South Africa’s National Institute for Communicable Diseases:

— Only about 30 percent of those hospitalized with COVID-19 in recent weeks have been seriously ill, less than half the rate as during the first weeks of previous pandemic waves.

— Average hospital stays for COVID-19 have been shorter this time – about 2.8 days compared to eight days.

— Just three percent of patients hospitalized recently with COVID-19 have died, versus about 20 percent in the country’s earlier outbreaks.

“At the moment, virtually everything points toward it being milder disease,” Willem Hanekom, director of the Africa Health Research Institute, said, citing the national institute’s figures and other reports. “It’s early days, and we need to get the final data. Often hospitalizations and deaths happen later, and we are only two weeks into this wave.”

In the meantime, scientists around the world are watching case counts and hospitalization rates, while testing to see how well current vaccines and treatments hold up. While Delta is still the dominant coronavirus strain worldwide, Omicron cases are popping up in dozens of countries, with South Africa the epicenter.

Pillay practices in the country’s Gauteng province, where the Omicron version has taken hold. With 16 million residents, It’s South Africa’s most populous province and includes the largest city, Johannesburg, and the capital, Pretoria. Gauteng saw a 400 percent rise in new cases in the first week of December, and testing shows Omicron is responsible for more than 90 percent of them, according to health officials.

Pillay says his COVID-19 patients during the last Delta wave “had trouble breathing and lower oxygen levels. Many needed hospitalization within days,” he said. The patients he’s treating now have milder, flu-like symptoms, such as body aches and a cough, he said.

Pillay is a director of an association representing some 5,000 general practitioners across South Africa, and his colleagues have documented similar observations about Omicron. Netcare, the largest private healthcare provider, is also reporting less severe cases of COVID-19.

But the number of cases is climbing. South Africa confirmed 22,400 new cases on Thursday and 19,000 on Friday, up from about 200 per day a few weeks ago. The new surge has infected 90,000 people in the past month, Minister of Health Joe Phaahla said Friday.

“Omicron has driven the resurgence,” Phaahla said, citing studies that say 70 percent of the new cases nationwide are from Omicron.

The coronavirus reproduction rate in the current wave – indicating the number of people likely to be infected by one person — is 2.5, the highest that South Africa has recorded during the pandemic, he said.

“Because this is such a transmissible variant, we’re seeing increases like we never saw before,” said Waasila Jassat, who tracks hospital data for the National Institute for Communicable Diseases.

Of the patients hospitalized in the current wave, 86 percent weren’t vaccinated against the coronavirus, Jassat said. The COVID-patients in South Africa’s hospitals now also are younger than at other periods of the pandemic: About two-thirds are under 40.

Jassat said that even though the early signs are that Omicron cases are less severe, the volume of new COVID-19 cases may still overwhelm South Africa’s hospitals and result in a higher number of severe symptoms and deaths.

“That is the danger always with the waves,” she said.

Read more:

South Africa readies hospitals as Omicron variant drives new COVID-19 wave

Omicron reported in 57 countries, hospitalizations set to rise: WHO

Omicron highlights urgency of vaccine equality, including in conflict zones: ICRC

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

M42 Bahrain and Mumtalakat break ground on Amana Healthcare – Bahrain’s first specialized long-term care and rehabilitation facility

– Groundbreaking ceremony marks Amana Healthcare’s entry into Bahrain and commitment to
delivering specialized care for the Kingdom’s people

– New facility will be the Kingdom’s first specialized long-term care provider offering post-acute
rehabilitation services
Operations scheduled to commence in 2025, Recruitment Day on 12 October in Manama will
employ the Kingdom’s most skilled local professional

Amana Healthcare, part of the M42 group, in
partnership with Bahrain Mumtalakat Holding Company (“Mumtalakat”), celebrated a groundbreaking
ceremony on 18 September 2024 to mark the start of construction on the Amana Healthcare facility in
Al Jasra, Bahrain. This milestone signifies Amana Healthcare’s entry into Bahrain and its commitment to
delivering world-class health solutions and specialized care for the health and wellbeing of people in the
Kingdom.
Members of Amana Healthcare – Bahrain’s Board of Directors attended the ceremony, including Dr.
Mohamed AlSaati, Acting CEO of M42 Bahrain and CEO of Amana Healthcare Bahrain and Khalid Hussain
Taqi, Managing Director – Local Impact Investments at Mumtalakat.
Commenting on the occasion Dr. AlSaati said, “This highly specialized new facility will address a critical
need in Bahrain, particularly long-term complex medical needs and post-acute rehabilitation. We are
proud to be partnering with Mumtalakat to address crucial gaps in the healthcare landscape, support
the vision of the country and create jobs for Bahrainis. The groundbreaking will mark the first step in this
journey, with momentum maintained through a Recruitment Day on 12 October 2024 in Manama to
engage and recruit the Kingdom’s most skilled local professionals. We’re looking forward to seeing
Amana Healthcare take shape in Bahrain ready to positively impact people in the Kingdom.”
Mr. Taqi added: “Mumtalakat is committed to investing in key sectors of Bahrain’s economy to benefit
and enrich the lives of its people. The launch of Amana Healthcare will allow us to leverage M42’s
expertise in delivering world-class care, ensuring that technology and innovation are at the forefront of
one of the most vital sectors – healthcare. The groundbreaking ceremony marks the start of the project,
which will ensure the efficient use of resources and further elevate the accessibility and quality of
healthcare provided to all citizens and residents. Furthermore, this aligns with our mandate to create
sustainable, long-term partnerships that deliver valuable services, while creating highly skilled job
opportunities.”
Scheduled to commence operations in 2025, the new facility will be the first international premium
provider of specialized long-term care and post-acute rehabilitation services in Bahrain – an innovative
approach set to revolutionize healthcare in the region and beyond.

The 15,000-square-meter, 100-bed facility will feature two large gyms, a hydrotherapy pool, two
majlises and gardens. The facility aims to offer world-class, tech-enabled services across its three wings.

 

Continue Reading

Health

UAE Employers Lead in Health Benefits Offering, But Employee Support Falls Short, Cigna Healthcare Study Reveals

 98% of UAE employees recognize the value of health programs, yet only 70%
feel supported, revealing a critical communication gap.
 International health insurance tops UAE’s EVP rankings, outpacing global trends,
but faces underutilization and implementation challenges.

A new Cigna Healthcare study reveals a significant disconnect
between employer intentions and employee perceptions regarding health and well-being
benefits in the UAE. While HR leaders rank international health insurance as the most preferred
employee value proposition (EVP) for boosting productivity and attracting talent, only 7 in 10
employees believe their employers proactively support their health and well-being.
The report, titled Harnessing Health – Measuring the Impact of Employee Health and Well-being
Benefits, is based on a survey of 1000 managers and directors in HR and Benefits functions in
the UAE, Hong Kong, Singapore, UK and US.
A compelling 98% of UAE employees agree that a robust health and well-being program
significantly boosts productivity and creates a more positive workplace. Reflecting this
sentiment, the study reveals that UAE companies offer more health benefits than their global
counterparts, underscoring the emphasis HR leaders place on employee well-being. However,
despite these efforts, many benefits remain underutilized, indicating a critical need for improved
access and awareness among employees.
Leah Cotterill, CEO of Cigna Healthcare Middle East and Africa (outside KSA), said, “Our
survey results clearly demonstrate that health and well-being benefits are powerful drivers of
workplace performance and talent attraction. While it’s promising to see that UAE companies
are offering more health benefits than their global counterparts, there’s still work to be done in
bridging the gap between availability and utilization. To truly maximize the potential of these
benefits, employers need to adopt a more strategic approach. This means not only offering
comprehensive packages, but ensuring they’re well-communicated, easily accessible, and
aligned with local cultural values. This is crucial for fostering a healthier, more satisfied, and
ultimately more productive workforce, giving businesses a competitive edge in today's global
market.”

Key findings in the UAE include:
 Strong Preference for Health Benefits: International health insurance is not only a key
part of the EVP but also the most favored by employees, ranking higher locally
compared to its fifth place globally. This preference is also shared equally with flexible
time off and working arrangements. The UAE presents more companies offering health
benefits than the global average.

 Employer Priorities: Employee health and well-being are top priorities for HR leaders,
on par with succession planning and leadership development (15%). Over half of these
leaders believe that robust health insurance plans promote a positive company culture
and enhance employee loyalty while effectively reducing absenteeism. UAE employee
rankings are amongst the highest in being proactively supported and valued for their
health and wellbeing.
 Gap in Benefit Utilization: Despite the widespread availability of health benefits
—offered by 93% of companies— there remains a significant underutilization issue, with
preventive health tools being the least utilized. This points to a potential gap in how
these benefits are communicated and understood by employees which could be a result
of insufficient awareness, cultural resistance, or limitations in support.
 Impact on Business Outcomes: More than half of HR leaders acknowledge the
positive impact of health benefits on key business metrics, particularly employee loyalty
and fostering a good company culture. While they see health insurance as beneficial in
reducing absenteeism, their confidence wanes when it comes to its effectiveness in
decreasing turnover, suggesting a need for targeted strategies to address specific local
challenges.
 Mental Health Support: There is still a gap in mental health support, as it is the least
offered benefit in the UAE (48%) among all markets surveyed. Additionally, only 7 in 10
employees in the UAE feel that their employers proactively support their health and well-
being.
 Health and Well Being: 98% of employees in UAE agree that robust health and well-
being program leads to better productivity and more positive work environment overall.

 

Continue Reading

Health

M42’s Mubadala Health Dubai prevents blindness in patient

 Consultant neurologist spots previously undetected signs in 75-year-old who was mistakenly
diagnosed with migraines
 Patient had temporal arteritis, which is inflammation of the medium-sized vessels of the
temporal artery and requires prompt medical attention
 Headache Clinic at Mubadala Health Dubai provides specialized treatment for headaches,
enabling sufferers to regain control of their lives

Dubai, United Arab Emirates, August 29, 2024: Mubadala Health Dubai, part of the M42 group,
provides specialized treatment for headaches, enabling sufferers to regain control of their lives. Utilizing
the latest research, innovative treatments and a holistic approach, Mubadala Health Dubai’s newly
launched Headache Clinic aims to improve the quality of life for patients with headaches and chronic
migraines. Recently, it helped treat a 75-year-old patient who risked possible blindness due to a
misdiagnosed condition.
The patient had been experiencing uncontrollable headaches for the past few months and had
previously been misdiagnosed with migraines. Due to the persistence of these headaches, the patient
was referred to Mubadala Health Dubai, where a correct diagnosis of temporal arteritis was made by Dr.
Mohammad Aghil Ghatali, Consultant Neurologist. Temporal arteritis is an inflammation of the
medium-sized vessels of the temporal artery. This condition commonly causes severe, localized
headaches typically felt in the temples. Other symptoms may include scalp tenderness, jaw pain while
chewing and visual disturbances. Notably, temporal arteritis can lead to visual loss, which poses a
significant risk of blindness if left untreated.
Inflammation of the temporal arteries can affect the arteries that supply blood to the eyes, leading to
reduced blood flow and potentially causing sudden vision loss. This condition, known as anterior
ischemic optic neuropathy, can result in permanent blindness if not treated quickly. It’s crucial to start
treatment with corticosteroids as soon as possible to reduce inflammation and prevent serious
complications like blindness.
Dr. Ghatali said: “I saw the patient in the clinic’s corridor rocking and pacing due to his pain. Immediate
treatment with high-dose prednisone not only relieved the patient’s headache but also prevented
potential blindness. This success story highlights the importance of accurate diagnosis and timely
intervention.”
The patient commented: “It was due to Dr. Ghatali’s extensive experience that my condition was
identified and treated. I am finally free of my debilitating symptoms, and I was shocked to learn that I
could have gone blind if my condition hadn’t been caught in time.”
Giant cell arteritis is a type of vasculitis, which means inflammation of the blood vessels. It is an
autoimmune disease, where the immune system mistakenly attacks the body’s own tissues. In this case,
the immune system attacks the blood vessels in the head. Both rheumatologists, who specialize in
autoimmune diseases, and neurologists, who focus on the nervous system, work together to manage
conditions like giant cell arteritis and other similar diseases.

As part of the clinic’s multidisciplinary approach, the patient was then referred to Dr. Nathalie
Chalhoub, Consultant Rheumatologist at Mubadala Health Dubai. Giant cell arteritis, also known as
temporal arteritis, is a type of vasculitis, characterized by inflammation of the blood vessels. It is an
autoimmune disease in which the immune system mistakenly attacks the body’s own tissues, specifically
targeting the blood vessels in the head. Both rheumatologists, who specialize in autoimmune diseases,
and neurologists, who focus on the nervous system, collaborate to manage conditions such as giant cell
arteritis and other similar diseases.
The clinic treats a variety of headaches from migraines to cluster, tension and sinus headaches. Its team
of experts conducts thorough evaluations, including medical history reviews and physical examinations,
to accurately diagnose the type and the cause of headaches and provide continuous support throughout
the treatment journey.

Continue Reading

Trending